Markers of the Extracellular Matrix May be Used to Understand Patient Endotyping & Therapeutical Effects in Patients with Steatotic Liver Disease

Time: 12:00 pm
day: Day 1 Seminar B Pre-Lunch Tracks


  • The extracellular matrix (ECM) plays a crucial role in liver fibrosis, making neoepitope markers valuable for understanding patient endotypes
  • Neoepitope markers of the ECM may be used as potential non-invasive test to displaying pharmacodynamic effects
  • The monitoring of the ECM remodelling may can contribute help understanding disease progression in SLD